Prognostic and Predictive Impact of uPA/PAI-1

PHASE3CompletedINTERVENTIONAL

Enrollment

689

Participants

Timeline

Start Date

June 30, 1993

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions

Breast Cancer

Interventions

DRUG

CMF Chemotherapy

All Listed Sponsors

collaborator

Technical University of Munich

OTHER

lead

Universitätsklinikum Hamburg-Eppendorf

OTHER

NCT01317108 - Prognostic and Predictive Impact of uPA/PAI-1 | Biotech Hunter | Biotech Hunter